We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

142 hedge funds and large institutions have $1.03B invested in Syndax Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 50 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 11

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

144% more call options, than puts

Call options by funds: $8.49M | Put options by funds: $3.48M

110% more capital invested

Capital invested by funds: $493M → $1.03B (+$541M)

108% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 24

43% more funds holding

Funds holding: 99 → 142 (+43)

11.63% more ownership

Funds ownership: 88.81% → 100.43% (+12%)

Holders
142
Holders Change
+43
Holders Change %
+43.43%
% of All Funds
2.51%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
55
Increased
50
Reduced
24
Closed
11
Calls
$8.49M
Puts
$3.48M
Net Calls
+$5.01M
Net Calls Change
+$5.13M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$32.1M
2
APM
Avidity Partners Management
Texas
+$30.2M
3
EAM
Eventide Asset Management
Massachusetts
+$25.9M
4
HM
HealthCor Management
New York
+$21.5M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$20.3M

Top Sellers

1
BI
BVF Inc
California
-$33M
2
MAM
MPM Asset Management
Massachusetts
-$27.2M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$14.8M
4
CS
Candriam SCA
Luxembourg
-$6.9M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$370K +$5.1K +246 +2%
JF
102
Jump Financial
Illinois
$356K +$332K +16,011 New
BFM
103
Boothbay Fund Management
New York
$341K +$318K +15,324 New
TI
104
Trexquant Investment
Connecticut
$334K -$276K -13,312 -47%
Group One Trading
105
Group One Trading
Illinois
$312K +$291K +14,021 New
ProShare Advisors
106
ProShare Advisors
Maryland
$273K +$255K +12,275 New
UBS Group
107
UBS Group
Switzerland
$260K +$221K +10,664 +1,066%
VEA
108
Virtus ETF Advisers
New York
$259K -$172K -8,270 -42%
MIM
109
MetLife Investment Management
New Jersey
$249K – – –
VF
110
Virtu Financial
New York
$243K +$227K +10,927 New
Barclays
111
Barclays
United Kingdom
$226K -$63.5K -3,061 -23%
TD Asset Management
112
TD Asset Management
Ontario, Canada
$225K +$209K +10,100 New
DCM
113
DAFNA Capital Management
California
$222K -$1.92M -92,713 -90%
GTCM
114
Gyon Technologies Capital Management
New Jersey
$211K +$197K +9,478 New
State Board of Administration of Florida Retirement System
115
State Board of Administration of Florida Retirement System
Florida
$204K +$190K +9,152 New
Susquehanna International Group
116
Susquehanna International Group
Pennsylvania
$203K +$190K +9,150 New
MLICM
117
Metropolitan Life Insurance Company (MetLife)
New York
$176K – – –
Citigroup
118
Citigroup
New York
$155K +$114K +5,476 +363%
Bank of Montreal
119
Bank of Montreal
Ontario, Canada
$141K +$60.4K +2,913 +96%
NWA
120
Navis Wealth Advisors
New York
$133K +$124K +6,000 New
SG Americas Securities
121
SG Americas Securities
New York
$107K +$99.7K +4,809 New
FC
122
FORA Capital
Florida
$97K +$90.9K +4,383 New
US Bancorp
123
US Bancorp
Minnesota
$96K – – –
Legal & General Group
124
Legal & General Group
United Kingdom
$92K +$16.7K +807 +24%
Pacer Advisors
125
Pacer Advisors
Pennsylvania
$56K +$52.6K +2,536 New
3 4
5
6 7

SNDX Hedge Fund Activity: Q4 2020 in Review

142 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q4 2020, worth a combined $1.03B — up 110% from $493M a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new SNDX positions and 11 closed out — a net gain of 44 holders — while 50 added to existing stakes and 24 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $32.1M. The largest seller was BVF Inc, cutting an estimated $33M.

  • 142 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q4 2020, up from 99 in Q3 2020.
  • Funds reported $1.03B of Syndax Pharmaceuticals stock for Q4 2020, up 110% quarter-over-quarter.
  • 55 funds opened new Syndax Pharmaceuticals positions in Q4 2020 and 11 closed out, a net change of +44 holders.
  • The largest Syndax Pharmaceuticals buyer in Q4 2020 was Citadel Advisors, an estimated $32.1M added.
  • The largest Syndax Pharmaceuticals seller in Q4 2020 was BVF Inc, an estimated $33M sold.

Based on aggregated 13F filings for Q4 2020.